Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Amag Pharmaceuticals (AMAG)

Amag Pharmaceuticals (AMAG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 477,469
  • Shares Outstanding, K 34,725
  • Annual Sales, $ 327,750 K
  • Annual Income, $ -466,460 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 0.89
  • Price/Sales 1.45
  • Price/Cash Flow N/A
  • Price/Book 1.85
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -2.30
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 11/13/20
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/20
See More
  • Average Estimate 0.01
  • Number of Estimates 4
  • High Estimate 0.11
  • Low Estimate -0.13
  • Prior Year -0.49
  • Growth Rate Est. (year over year) +102.04%

Price Performance

See More
Period Period Low Period High Performance
1-Month
13.35 +3.00%
on 10/14/20
13.76 -0.07%
on 11/13/20
+0.38 (+2.84%)
since 10/13/20
3-Month
8.62 +59.51%
on 09/24/20
13.80 -0.36%
on 10/01/20
+3.18 (+30.09%)
since 08/13/20
52-Week
4.41 +211.79%
on 03/18/20
13.80 -0.36%
on 10/01/20
+4.06 (+41.90%)
since 11/13/19

Most Recent Stories

More News
Sensorion appoints pharmaceutical industry veteran Scott D. Myers as Chairman of the Board and Independent Director

Regulatory News:

DVAX : 12.79 (-1.92%)
HARP : 23.01 (+0.09%)
AMAG : 13.75 (+0.15%)
Aquestive Therapeutics Strengthens Board of Directors with Appointments of Julie Krop, M.D., and Marco Taglietti, M.D., and Announces Resignation of Douglas K. Bratton from Board of Directors

WARREN, N.J., Feb. 09, 2021 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical company focused on developing and commercializing differentiated products that address patients’...

AQST : 4.39 (-8.73%)
FRLN : 6.48 (unch)
AMAG : 13.75 (+0.15%)
VRTX : 456.97 (-1.88%)
SYK : 390.97 (+0.34%)
SCYX : 1.2800 (-3.03%)
ABBV : 181.50 (-0.15%)
DCTH : 11.86 (-6.17%)
NRX : 0.14 (+7.69%)
AMAG Pharmaceuticals Files Submission in Response To the Food And Drug Administration’s Notice of Opportunity for a Hearing and Proposal To Withdraw Approval of Makena® (hydroxyprogesterone caproate injection)

WALTHAM, Mass., Dec. 14, 2020 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. has submitted its response to the FDA’s Notice of Opportunity for a Hearing (“NOOH”) regarding the Agency’s proposal...

AMAG : 13.75 (+0.15%)

Business Summary

AMAG Pharmaceuticals, Inc. is a biopharmaceutical company that utilizes its proprietary nanoparticle technology for the development and commercialization of therapeutic iron compounds to treat anemia and novel imaging agents to aid in the diagnosis of cancer and cardiovascular disease. Ferumoxytol, the...

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 13.76
1st Resistance Point 13.76
Last Price 13.75
1st Support Level 13.75
2nd Support Level 13.74
3rd Support Level N/A

See More

52-Week High 13.80
Last Price 13.75
Fibonacci 61.8% 10.21
Fibonacci 50% 9.10
Fibonacci 38.2% 8.00
52-Week Low 4.41

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar